tiprankstipranks
Advertisement
Advertisement

OLMA Stock Latest News

Olema Pharmaceuticals: Clinical Momentum and Strategic Flexibility Support Buy Rating and Maintain $38 Price Target
RatingsOlema Pharmaceuticals: Clinical Momentum and Strategic Flexibility Support Buy Rating and Maintain $38 Price Target
9d ago
OLMA
Olema Pharmaceuticals: Buy Rating Reiterated as Pipeline Progress Supports Attractive Risk/Reward with Unchanged $62 Price Target
PremiumRatings
Olema Pharmaceuticals: Buy Rating Reiterated as Pipeline Progress Supports Attractive Risk/Reward with Unchanged $62 Price Target
11d ago
OLMA
Olema Oncology announces collaboration, supply agreement with Bayer
PremiumThe Fly
Olema Oncology announces collaboration, supply agreement with Bayer
17d ago
OLMA
Olema, Bayer launch OP-3136 prostate cancer collaboration
PremiumCompany Announcements
Olema, Bayer launch OP-3136 prostate cancer collaboration
17d ago
8K
OLMA
Olema Highlights Encouraging OP-3136 Phase 1 Oncology Results
PremiumCompany Announcements
Olema Highlights Encouraging OP-3136 Phase 1 Oncology Results
21d ago
8K
OLMA
Citi opens ‘upside 90-day catalyst watch’ on Olema Oncology
PremiumThe FlyCiti opens ‘upside 90-day catalyst watch’ on Olema Oncology
29d ago
OLMA
Olema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts
Premium
Ratings
Olema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts
30d ago
OLMA
Olema Oncology price target lowered to $35 from $38 at Guggenheim
Premium
The Fly
Olema Oncology price target lowered to $35 from $38 at Guggenheim
30d ago
PFE
OLMA
Olema Pharmaceuticals: Differentiated KAT6i and Palazestrant Pipeline Catalysts Underpin Buy Rating
PremiumRatings
Olema Pharmaceuticals: Differentiated KAT6i and Palazestrant Pipeline Catalysts Underpin Buy Rating
1M ago
OLMA
Olema Oncology reports Q1 EPS (52c), consensus (54c)
PremiumThe Fly
Olema Oncology reports Q1 EPS (52c), consensus (54c)
1M ago
OLMA
Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point
PremiumCompany Announcements
Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point
1M ago
8K
OLMA
Olema Pharmaceuticals Adds Veteran Director to Support Growth
PremiumCompany Announcements
Olema Pharmaceuticals Adds Veteran Director to Support Growth
1M ago
8K
OLMA
Olema Oncology to present initial clinical data for OP-3136 at ASCO
PremiumThe FlyOlema Oncology to present initial clinical data for OP-3136 at ASCO
2M ago
OLMA
Olema Oncology announces preclinical data for Palazestrant
Premium
The Fly
Olema Oncology announces preclinical data for Palazestrant
2M ago
OLMA
Olema Oncology initiated with a Peer Perform at Wolfe Research
Premium
The Fly
Olema Oncology initiated with a Peer Perform at Wolfe Research
3M ago
OLMA
Olema Oncology assumed with a Buy at Jefferies
PremiumThe Fly
Olema Oncology assumed with a Buy at Jefferies
3M ago
OLMA
Olema Oncology price target raised to $58 from $55 at JPMorgan
PremiumThe Fly
Olema Oncology price target raised to $58 from $55 at JPMorgan
3M ago
OLMA
Olema Oncology price target lowered to $27 from $38 at Goldman Sachs
PremiumThe Fly
Olema Oncology price target lowered to $27 from $38 at Goldman Sachs
3M ago
OLMA
Olema Oncology price target lowered to $38 from $40 at Guggenheim
PremiumThe Fly
Olema Oncology price target lowered to $38 from $40 at Guggenheim
3M ago
AZN
CHRO
Olema Oncology price target raised to $62 from $60 at Citi
PremiumThe FlyOlema Oncology price target raised to $62 from $60 at Citi
3M ago
OLMA
Olema Pharmaceuticals: Palazestrant Phase III Upside and Differentiated Pipeline Underpin Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Palazestrant Phase III Upside and Differentiated Pipeline Underpin Buy Rating
3M ago
OLMA
Buy Rating Reaffirmed on Palazestrant’s Differentiated Phase 3 Program and Favorable Risk‑Reward Profile for Olema
Premium
Ratings
Buy Rating Reaffirmed on Palazestrant’s Differentiated Phase 3 Program and Favorable Risk‑Reward Profile for Olema
3M ago
OLMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >